- Zentek (ZTEK, Financial) will not extend CEO Greg Fenton's consulting contract, which expires on March 31, 2026.
- The board has begun searching for a new CEO to drive the company's shift from R&D to commercialization.
- The current executive team will lead Zentek until a new CEO is appointed.
Zentek Ltd. (NASDAQ:ZTEK), an intellectual property technology development and commercialization company, announced that the consulting contract for its Chief Executive Officer, Greg Fenton, will not be extended beyond March 31, 2026. During Fenton's seven-year tenure as CEO, he has played a pivotal role in steering Zentek toward growth and diversification.
As the company embarks on this leadership transition, its board of directors has initiated a search for Fenton's successor. The new CEO is expected to focus on moving Zentek from its research and development stage to the commercialization phase. In the interim, the current executive team will continue to lead the company.
With a commitment to enhancing its commercial prospects, Zentek emphasizes its strategic vision of driving innovation through its patented technology platform, ZenGUARD™, which significantly improves the filtration efficiency of surgical masks and HVAC filters. Based in Guelph, Ontario, Zentek continues to advance its aptamer-based platform technology in partnership with McMaster University, targeting diagnostic and therapeutic markets.
